S
Shahzaib Ahmad
Publications - 15
Citations - 58
Shahzaib Ahmad is an academic researcher. The author has contributed to research in topics: Medicine & Disease. The author has an hindex of 5, co-authored 15 publications receiving 58 citations.
Papers
More filters
Journal ArticleDOI
Targeting Oxidative Stress Mechanisms to Treat Alzheimer's and Parkinson's Disease: A Critical Review
Abdullahi Tunde Aborode,Manas V. Pustake,W. A. Awuah,Mariam Alwerdani,Parth Shah,Rohan Yarlagadda,Shahzaib Ahmad,Inês F. Silva Correia,Ayush Chandra,Esther Nansubuga,Toufik Abdul-Rahman,Aashna Mehta,Omar Ali,Shekinah Obinna Amaka,Yves Miel H Zuniga,A.D. Shkodina,Oko Christian Inya,Bairong Shen,Athanasios Alexiou +18 more
TL;DR: To better understand how oxidative stress contributes to neurodegenerative diseases (such as Alzheimer's and Parkinson's), the medicinal qualities of medicines that target markers in the cellular oxidative pathways are analyzed.
Journal ArticleDOI
Lipid Lowering Therapy: An Era Beyond Statins.
Toufik Abdul-Rahman,Syed Muhammad Bahar Ali Bukhari,Emilia Herrera,W. A. Awuah,Jannel A. Lawrence,Heloisa de Andrade,Neal Patel,Rohan A. Shah,Raheel Shaikh,Camilo Andrés Avendaño-Capriles,Sebahat Ulusan,Shahzaib Ahmad,A. Corriero,Adriana Mares,A. Goel,Adrija Hajra,Dhrubajyoti Bandyopadhyay,Rahul Gupta +17 more
TL;DR: A review of non-statin lipid-lowering therapies can be found in this paper , where the authors examined recent advances and emerging research, including gene-based therapy, small interfering RNAs, Antisense oligonucleotides, Adeno-associated virus vectors, CRISPR/Cas9 based therapeutics, and non-coding RNA therapy.
Journal ArticleDOI
Seven classes of antiviral agents
Aleksandr Ianevski,Shahzaib Ahmad,Kraipit Anunnitipat,Valentyn Oksenych,Eva Zusinaite,Tanel Tenson,Magnar Bjørås,Denis E. Kainov +7 more
TL;DR: In this paper , the authors reviewed seven classes of antiviral agents: neutralizing antibodies, neutralizing recombinant soluble human receptors, antiviral CRISPR/Cas systems, interferons and small molecules.
Journal ArticleDOI
OMICs Technologies for Natural Compounds-based Drug Development.
Abdullahi Tunde Aborode,W. A. Awuah,T. Mikhailova,Toufik Abdul-Rahman,Samantha Pavlock,Esther Nansubuga,Mrinmoy Kundu,Rohan Yarlagadda,Manas V. Pustake,I. F. S. Correia,Qasim Mehmood,Parth Shah,Aashna Mehta,Shahzaib Ahmad,A. Asekun,Shekinah Obinna Amaka,A.D. Shkodina,Athanasios Alexiou +17 more
TL;DR: This review summarizes technologies that are effective in natural source drug discovery and aid in a more precisely targeted pharmaceutical approach, including RNA interference or CRISPR technology.
Journal ArticleDOI
COVID-19, bubonic and meningitis in Democratic Republic of Congo: the confluence of three plagues at a challenging time
Abdullahi Tunde Aborode,W. A. Awuah,Aashna Mehta,Abdul-Rahman Toufik,Shahzaib Ahmad,A. Corriero,Ana Carla dos Santos Costa,Esther Nansubuga,Elif Naz Geçer,Katerina Namaal Bel-Nono,Aymar C Akilimali,Christian Inya Oko,Yves Miel H Zuñiga +12 more
TL;DR: The Democratic Republic of Congo has been recorded as one of the povertystricken countries globally, with over 70% of the individuals living in poverty, and COVID19 has worsened this situation further as the majority lost their jobs, and the healthcare system capacity struggles to mitigate the impact of the ongoing pandemic.